Using AI to improve brain imaging for Alzheimer's disease

AI-Enhanced Brain PET Imaging for Alzheimer's Disease

NIH-funded research Stanford University · NIH-10691406

This study is working on using smart computer technology to make brain scans for Alzheimer's disease safer and easier by using less radioactive material, which could help doctors spot the disease earlier and improve care for people with dementia.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10691406 on NIH RePORTER

What this research studies

This research focuses on enhancing brain PET imaging techniques for Alzheimer's disease by utilizing artificial intelligence. The project aims to develop convolutional neural network methods that can significantly reduce the amount of radiotracer needed for imaging, making it safer and more accessible for patients. By improving the quality of imaging for commonly used radiotracers, the research seeks to enable better understanding of the disease's progression and facilitate earlier diagnosis. Ultimately, this could lead to more effective monitoring and treatment strategies for individuals with or at risk of dementia.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at high risk for developing dementia.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective brain imaging techniques for diagnosing and monitoring Alzheimer's disease.

How similar studies have performed: Previous research has shown promise in using AI to enhance imaging techniques, suggesting that this approach could lead to significant advancements in the field.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.